title: Regulating cell-based regenerative medicine: the challenges ahead.
abstract: Those working in the regenerative medicine field currently face numerous regulatory and related challenges. This Perspective captures some of the key ideas of a UK-based working group drawn from academic, clinical and industrial communities and also identifies some key steps that should be taken in the UK and elsewhere to address these challenges.
authors.affiliation: UCL Institute of Ophthalmology, Bath St, London EC1V 9EL, UK.
authors.forename: Robin R
authors.initials: RR
authors.lastname: Ali
authors.forename: Anthony P
authors.initials: AP
authors.lastname: Hollander
authors.forename: Paul
authors.initials: P
authors.lastname: Kemp
authors.forename: Andrew
authors.initials: A
authors.lastname: Webster
authors.forename: Martin R
authors.initials: MR
authors.lastname: Wilkins
mesh_terms: D064987:Cell- and Tissue-Based Therapy / Q000639:trends*; D002986:Clinical Trials as Topic / Q000379:methods; D015316:Genetic Therapy / Q000331:legislation & jurisprudence / Q000639:trends*; D033161:Government Regulation; D044968:Regenerative Medicine / Q000331:legislation & jurisprudence / Q000379:methods* / Q000639:trends*; D012959:Socioeconomic Factors; D006113:United Kingdom